Page last updated: 2024-10-24

chlorambucil and Atypical Mycobacterial Infection, Disseminated

chlorambucil has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"Treatment with clarithromycin, ethambutol and rifabutin resulted in improvement of anaemia and general health as well as in regression of lymphadenopathy and splenomegaly."1.31Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. ( Bodmer, T; Krebs, T; Lämmle, B; Zimmerli, S, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krebs, T1
Zimmerli, S1
Bodmer, T1
Lämmle, B1

Other Studies

1 other study available for chlorambucil and Atypical Mycobacterial Infection, Disseminated

ArticleYear
Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia.
    Journal of internal medicine, 2000, Volume: 248, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercula

2000